Free Trial

Windtree Therapeutics (WINT) Short Interest Ratio & Short Volume

Windtree Therapeutics logo
$0.75 -0.04 (-5.00%)
Closing price 04:00 PM Eastern
Extended Trading
$0.75 0.00 (-0.01%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Windtree Therapeutics Short Interest Data

Windtree Therapeutics (WINT) has a short interest of 50,800 shares, representing 6.78% of the float (the number of shares available for trading by the public). This marks a -23.61% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 751,839 shares to cover all short positions.

Current Short Interest
50,800 shares
Previous Short Interest
66,500 shares
Change Vs. Previous Month
-23.61%
Dollar Volume Sold Short
$59,436.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
3,652,000 shares
Float Size
748,800 shares
Short Percent of Float
6.78%
Today's Trading Volume
221,190 shares
Average Trading Volume
751,839 shares
Today's Volume Vs. Average
29%
Short Selling Windtree Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Windtree Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

WINT Short Interest Over Time

WINT Days to Cover Over Time

WINT Percentage of Float Shorted Over Time

Windtree Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202550,800 shares $59,436.00 -23.6%6.8%0 $1.17
4/15/202566,500 shares $78,470.00 -76.2%8.9%0 $1.18
3/31/2025279,300 shares $351,918.00 +466.5%37.3%0.1 $1.26
3/15/202549,300 shares $101,065.00 -40.6%6.6%0 $2.05
2/28/202583,000 shares $263,940.00 +44.9%11.1%0.3 $3.18
2/15/202557,300 shares $393,651.00 -67.1%7.7%0.4 $6.87
1/31/2025174,100 shares $22,737.46 -80.9%1.6%0 $0.13
1/15/2025909,000 shares $220,887.00 +72.4%8.3%0.3 $0.24
12/31/2024527,200 shares $184,150.96 +6.1%5.9%0.2 $0.35
12/15/2024497,000 shares $175,639.80 +228.5%5.6%0.3 $0.35
11/30/2024151,300 shares $80,264.65 +389.6%1.7%0.1 $0.53
11/15/202430,900 shares $14,680.59 -84.2%0.4%0 $0.48
10/31/2024195,700 shares $137,655.38 +301.9%2.4%0.1 $0.70
10/15/202448,700 shares $32,142.00 -50.7%1.4%0 $0.66
9/30/202498,700 shares $235,893.00 +174.9%2.8%0.1 $2.39
9/15/202435,900 shares $113,803.00 -65.9%2.6%0 $3.17
8/31/2024105,400 shares $854,794.00 -6.8%23.9%0.1 $8.11
8/15/2024113,100 shares $1.26 million -56.8%25.6%0.1 $11.14
7/31/2024261,700 shares $2.39 million +455.6%59.3%0.3 $9.12
7/15/202447,100 shares $174,270.00 -17.5%10.7%1.5 $3.70
6/30/202457,100 shares $183,291.00 +21.2%12.9%1.8 $3.21
6/15/202447,100 shares $146,010.00 +20.8%10.7%1.7 $3.10
5/31/202439,000 shares $138,060.00 +89.3%9.1%1.6 $3.54
5/15/202420,600 shares $94,784.72 +62.2%4.8%0.8 $4.60
4/30/202412,700 shares $63,881.00 +388.5%3.0%0.6 $5.03
4/15/20242,600 shares $19,656.00 -93.5%N/A0.2 $7.56
3/31/202439,700 shares $14,053.80 +30.2%0.5%0.2 $0.35
3/15/202430,500 shares $10,370.00 -47.8%0.4%0.1 $0.34
2/29/202458,400 shares $21,024.00 -42.2%0.8%0.2 $0.36
2/15/2024101,100 shares $36,092.70 -56.0%1.9%0.3 $0.36
1/31/2024229,600 shares $96,500.88 +353.8%5.3%0.8 $0.42
1/15/202450,600 shares $28,953.32 +25.6%1.0%0.2 $0.57
12/31/202340,300 shares $28,975.70 +108.8%N/A0.3 $0.72
12/15/202319,300 shares $14,089.00 -55.5%0.5%0.2 $0.73
11/30/202343,400 shares $50,344.00 -13.4%1.1%0.4 $1.16
11/15/202350,100 shares $46,081.98 -22.5%1.2%0.5 $0.92
10/31/202364,600 shares $67,830.00 -65.8%1.5%0.5 $1.05
10/15/2023188,900 shares $236,125.00 +540.3%4.3%1.5 $1.25
9/30/202329,500 shares $27,983.70 +81.0%0.7%0.2 $0.95
9/15/202316,300 shares $18,745.00 +27.3%0.4%0.1 $1.15
The DOJ Just Said Your Money Isn’t Yours (Ad)

What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.

Get your free guide now by clicking here >>
8/31/202312,800 shares $14,095.36 -75.8%2.0%0.1 $1.10
8/15/202352,800 shares $85,536.00 +294.0%7.9%0.2 $1.62
7/31/202313,400 shares $18,626.00 +162.8%2.0%0 $1.39
7/15/20235,100 shares $6,834.00 -42.1%N/A0 $1.34
6/30/20238,800 shares $11,000.00 -90.5%N/A0 $1.25
6/15/202392,500 shares $142,450.00 -2.9%N/A0.1 $1.54
5/31/202395,300 shares $121,984.00 -51.2%N/A0.1 $1.28
5/15/2023195,100 shares $290,699.00 +64.4%N/A0.2 $1.49
4/30/2023118,700 shares $194,668.00 +136.9%68.7%0.1 $1.64
4/15/202350,100 shares $219,438.00 +87.6%8.5%0.1 $4.38
3/31/202326,700 shares $133,233.00 -2.9%4.7%0.2 $4.99
3/15/202327,500 shares $132,550.00 -53.0%4.9%0.3 $4.82
2/28/202358,500 shares $367,380.00 +604.8%10.3%0.6 $6.28
2/15/20238,300 shares $1,232.55 -98.9%N/A0.1 $0.15
1/31/2023754,800 shares $120,768.00 +16.1%N/A1.4 $0.16
1/15/2023650,300 shares $143,033.49 -28.2%N/A1.3 $0.22
12/30/2022905,900 shares $154,003.00 -28.7%N/A2 $0.17
12/15/20221,270,000 shares $226,060.00 +4.1%N/A1.4 $0.18
11/30/20221,220,000 shares $234,850.00 -3.2%N/A1.3 $0.19
11/15/20221,260,000 shares $110,250.00 -9.4%5.3%1.2 $0.09
10/31/20221,390,000 shares $238,385.00 -10.9%7.4%0.7 $0.17
10/15/20221,560,000 shares $379,704.00 +26.8%8.3%0.8 $0.24
9/30/20221,230,000 shares $369,123.00 +44.6%6.5%0.7 $0.30
9/15/2022850,900 shares $314,662.82 -8.3%4.5%0.6 $0.37
8/31/2022928,000 shares $365,632.00 +21.9%5.1%0.7 $0.39
8/15/2022761,500 shares $288,608.50 +0.0%4.2%0.6 $0.38
7/31/2022761,200 shares $299,913.56 -19.9%4.3%3.1 $0.39
7/15/2022950,700 shares $384,558.15 +6.8%5.4%3.4 $0.40
6/30/2022890,200 shares $371,213.40 +3.6%5.1%1.1 $0.42
6/15/2022858,900 shares $365,032.50 -7.5%4.9%1.1 $0.43
5/31/2022928,500 shares $452,179.50 +18.9%5.4%1.2 $0.49
5/15/2022781,200 shares $429,660.00 -12.1%4.5%1.1 $0.55
4/30/2022888,700 shares $657,282.52 +104.6%5.3%1.3 $0.74
4/15/2022434,400 shares $462,679.44 -0.5%2.6%0.6 $1.07
3/31/2022436,400 shares $497,496.00 -9.1%2.6%3.9 $1.14
3/15/2022480,100 shares $458,495.50 +10.4%2.9%3.4 $0.96
2/28/2022434,800 shares $465,236.00 -21.0%2.6%3.1 $1.07
2/15/2022550,600 shares $578,130.00 +60.9%3.3%3.4 $1.05
1/31/2022342,200 shares $386,686.00 -30.6%2.0%1.9 $1.13
1/15/2022493,000 shares $734,570.00 +3.1%2.9%2.5 $1.49
12/31/2021478,000 shares $769,580.00 -19.7%2.8%1.8 $1.61
12/15/2021595,400 shares $940,732.00 -12.9%3.5%1.7 $1.58
11/30/2021683,600 shares $1.17 million -5.3%4.2%2 $1.71
11/15/2021721,900 shares $1.24 million -15.1%4.5%2 $1.72
10/29/2021849,800 shares $1.51 million -21.3%5.6%2.2 $1.78
10/15/20211,080,000 shares $2.46 million +6.9%6.9%1.6 $2.28
9/30/20211,010,000 shares $2.08 million -18.6%6.5%1.6 $2.06
9/15/20211,240,000 shares $2.26 million -0.8%8.0%2.1 $1.82
8/31/20211,250,000 shares $2.45 million -27.3%8.1%1.8 $1.96
8/13/20211,720,000 shares $3.13 million +10.3%11.2%0.6 $1.82
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
7/30/20211,560,000 shares $2.95 million +1.3%19.8%0.5 $1.89
7/15/20211,540,000 shares $2.82 million -1.9%19.5%0.5 $1.83
6/30/20211,570,000 shares $3.60 million +6.1%19.9%0.5 $2.29
6/15/20211,480,000 shares $3.37 million +108.2%18.8%0.5 $2.28
5/28/2021710,900 shares $1.26 million +10.8%9.0%0.2 $1.77
5/14/2021641,500 shares $1.08 million +95.6%8.1%0.9 $1.68
4/30/2021328,000 shares $734,720.00 +35.9%4.7%0.7 $2.24
4/15/2021241,400 shares $555,220.00 +87.1%3.5%0.6 $2.30
3/31/2021129,000 shares $276,060.00 -18.2%3.9%0.4 $2.14
3/15/2021157,600 shares $660,344.00 +81.4%4.6%1 $4.19
2/26/202186,900 shares $438,410.50 +1.6%2.5%1.8 $5.05
2/12/202185,500 shares $469,395.00 -3.9%2.5%3.6 $5.49
1/29/202189,000 shares $501,070.00 -0.8%2.6%5 $5.63
1/15/202189,700 shares $554,346.00 No Change2.6%6.5 $6.18

WINT Short Interest - Frequently Asked Questions

What is Windtree Therapeutics' current short interest?

Short interest is the volume of Windtree Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 50,800 shares of WINT short. 6.78% of Windtree Therapeutics' shares are currently sold short. Learn More on Windtree Therapeutics' current short interest.

What is a good short interest percentage for Windtree Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.78% of Windtree Therapeutics' floating shares are currently sold short.

Is Windtree Therapeutics' short interest increasing or decreasing?

Windtree Therapeutics saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 50,800 shares, a decrease of 23.6% from the previous total of 66,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Windtree Therapeutics' float size?

Windtree Therapeutics currently has issued a total of 3,652,000 shares. Some of Windtree Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Windtree Therapeutics currently has a public float of 748,800 shares.

How does Windtree Therapeutics' short interest compare to its competitors?

6.78% of Windtree Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Windtree Therapeutics: Relmada Therapeutics, Inc. (6.12%), Synlogic, Inc. (0.44%), Trinity Biotech plc (0.92%), Eterna Therapeutics Inc. (0.55%), Marker Therapeutics, Inc. (1.60%), Rallybio Co. (1.83%), Hoth Therapeutics, Inc. (1.08%), NextCure, Inc. (0.84%), Cellectar Biosciences, Inc. (3.44%), Imunon, Inc. (7.33%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Windtree Therapeutics stock?

Short selling WINT is an investing strategy that aims to generate trading profit from Windtree Therapeutics as its price is falling. WINT shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Windtree Therapeutics?

A short squeeze for Windtree Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of WINT, which in turn drives the price of the stock up even further.

How often is Windtree Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WINT, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:WINT) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners